Patents by Inventor Leendert W. Neuteboom

Leendert W. Neuteboom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240110193
    Abstract: The present invention is in the field of molecular biology and relates to improved methods for plant transformation and to polynucleotides and polypeptides for achieving the same.
    Type: Application
    Filed: October 9, 2020
    Publication date: April 4, 2024
    Inventors: Thaquoris Pitt, Sean McAdams, Minesh Patel, Mary F. Dubois, Leendert W. Neuteboom
  • Publication number: 20230183686
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: September 16, 2022
    Publication date: June 15, 2023
    Inventors: Leendert W. Neuteboom, John A. McElver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle
  • Publication number: 20230107997
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: September 16, 2022
    Publication date: April 6, 2023
    Inventors: Leendert W. NEUTEBOOM, John A. MCELVER, Rosa DE PINHO BARROCO, Chris DE WILDE, Max Fabian FELLE
  • Patent number: 11608499
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: March 21, 2023
    Assignee: BASF PLANT SCIENCE COMPANY GMBH
    Inventors: Leendert W. Neuteboom, John A. McElver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle
  • Publication number: 20230049124
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: September 16, 2022
    Publication date: February 16, 2023
    Inventors: Leendert W. NEUTEBOOM, John A. Mcelver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle
  • Publication number: 20230024869
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: September 16, 2022
    Publication date: January 26, 2023
    Inventors: Leendert W. NEUTEBOOM, John A. McElver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle
  • Publication number: 20190309290
    Abstract: Methods for modification of target nucleic acids. The method involves a construct in which guide RNA is covalently linked to donor RNA (fusion NA) to be introduced into the target nucleic acid by homologous recombination and is based on the introduction of a nuclease, e.g. CRISPR or TALEN, into the cell containing the target nucleic acid. The fusion NA may be introduced as a DNA vector.
    Type: Application
    Filed: April 20, 2017
    Publication date: October 10, 2019
    Inventors: Leendert W. Neuteboom, John A. McElver, Rosa De Pinho Barroco, Chris De Wilde, Max Fabian Felle